Myocardial perfusion imaging (MPI) is a highly sensitive and specific test for noninvasive detection of coronary artery disease. Therefore, in patients with negative MPI results, further noninvasive testing is usually not pursued. We report a series of patients with negative MPI results in whom 64-slice computed tomographic coronary angiography accurately predicted flow-limiting coronary lesions requiring subsequent revascularization.
Myocardial perfusion imaging (MPI) is a highly sensitive and specific test for noninvasive detection of coronary artery disease. Therefore, in patients with negative MPI results, further noninvasive testing is usually not pursued. We report a series of patients with negative MPI results in whom 64-slice computed tomographic coronary angiography accurately predicted flow-limiting coronary lesions requiring subsequent revascularization.
yocardial perfusion imaging (MPI) is a highly sensitive and specific test for the diagnosis of coronary artery disease (CAD), with reported sensitivity of 87% to 89% and specificity of 73% to 75% (1) . In patients with symptoms suggestive of angina, MPI is often done as the primary diagnostic test. Although a negative MPI result usually portends a very good prognosis (2), it does not rule out CAD, especially in patients who have a moderate pretest probability of CAD. As a result, in patients with persistent symptoms of chest pain, a moderate risk of CAD, and a negative MPI result, further testing may still be performed to convincingly rule out obstructive coronary stenoses.
Computed tomographic coronary angiography (CTCA) is a rapidly evolving noninvasive modality for doing coronary angiography that has been shown to have acceptable sensitivity and specificity (3) . However, its utility in predicting CAD in patients with normal MPI scans is unknown. We report a series of patients in whom 64-slice CTCA was performed after a negative or low-probability MPI result due to continued clinical suspicion. In each of these cases, significant flow-limiting disease was suggested by the CTCA and then subsequently confirmed by invasive coronary angiography.
METHODS
A series of "moderate"-risk patients underwent a dualisotope myocardial perfusion study in the clinical setting of chest pain. A weight-adjusted dose of thallium (on average 3 mCi) was injected in the resting condition. Subsequently, during adenosine infusion or following peak treadmill exercise, the patients were injected with a second dose of M approximately 24 mCi of 99m Tc-MIBI, and a gated acquisition was performed. Corresponding tomographic slices in the stress and resting phases were directly compared using a visual qualitative inspection to assess for perfusion. Wall motion, thickening, and an estimated left ventricular ejection fraction were generated from a separate review of the gated data. All the perfusion images were read by experienced readers.
Due to continued clinical suspicion and ongoing symptoms of angina, these patients underwent 64-slice CTCA (LightSpeed VCT, GE Healthcare) to further define coronary anatomy. Patients' heart rates were lowered using pre-CT beta-blockade where applicable, with additional intravenous beta-blockers given at the time of the scan. Sublingual nitroglycerine was given prior to the scan as a part of the routine protocol. CTCAs were interpreted by a reader with level 3-equivalent experience in CTCA (4) .
In each of these cases, the results from the CT suggested "high-grade" lesions in one or more arteries. Invasive angiography was performed, and the results of the CTCA were then compared with those obtained from conventional angiography.
RESULTS
CTCA demonstrated single-vessel CAD involving the left anterior descending artery in two patients. Two-vessel disease involving the left anterior descending and right coronary arteries was detected on CTCA in two patients. Three-vessel CAD was found in the remaining three patients (Table) . In all patients, there was excellent anatomic correlation with invasive angiography (Figures 1 and 2) .
Based on angiography results, patients with either single or two-vessel disease underwent percutaneous coronary intervention with drug-eluting stent implantation. All three patients with triple-vessel disease underwent coronary artery bypass surgery. DISCUSSION A "normal" MPI defines a population with a low probability of future cardiac events (2) . However, there are well-described false-negative MPI scans (5) . This may be due to "balanced disease" or lack of a flow-limiting lesion under testing conditions. As a result, in some patients with a negative MPI scan, further testing to rule out CAD may be warranted. This is especially true in the setting of continued symptoms.
Multislice CTCA has recently emerged as a noninvasive modality for detection of CAD, with high sensitivity and specificity reported in the literature (3) . Like invasive angiography, multislice CTCA can accurately reveal distribution of atherosclerotic plaques in the coronary bed and the degree of flow limitation. As a result, multislice CTCA can potentially help identify patients who have near-normal MPI scans due to balanced multivessel disease.
In this case series, CTCA was able to accurately diagnose single-vessel and multivessel disease despite normal MPI scans in a population with a moderate pretest probability of CAD. Nuclear perfusion scan is often the first test performed in the evaluation of a cardiac patient with moderate pretest probability of CAD. In some of these patients with normal or "near-normal" nuclear scans, further testing is warranted due to ongoing unexplained symptoms or continued concern for the patient's well-being. In these circumstances, CTCA may be a complementary noninvasive testing modality for the further evaluation of patients with negative MPI scans.
